Long-term use of protease inhibitors is associated with bone mineral density loss.

MLA

Kinai, Ei, et al. “Long-Term Use of Protease Inhibitors Is Associated with Bone Mineral Density Loss.” AIDS Research and Human Retroviruses, vol. 30, no. 6, June 2014, pp. 553–59. EBSCOhost, https://doi.org/10.1089/AID.2013.0252.

APA

Kinai, E., Nishijima, T., Mizushima, D., Watanabe, K., Aoki, T., Honda, H., Yazaki, H., Genka, I., Tanuma, J., Teruya, K., Tsukada, K., Gatanaga, H., Kikuchi, Y., & Oka, S. (2014). Long-term use of protease inhibitors is associated with bone mineral density loss. AIDS Research and Human Retroviruses, 30(6), 553–559. https://doi.org/10.1089/AID.2013.0252

Chicago

Kinai, Ei, Takeshi Nishijima, Daisuke Mizushima, Koji Watanabe, Takahiro Aoki, Haruhito Honda, Hirohisa Yazaki, et al. 2014. “Long-Term Use of Protease Inhibitors Is Associated with Bone Mineral Density Loss.” AIDS Research and Human Retroviruses 30 (6): 553–59. doi:10.1089/AID.2013.0252.